Mrna Sequencing Market Scope And Analysis

Report Code : TIPRE00038963
Category : Life Sciences

No. of Pages : 150

Buy Now

mRNA Sequencing Market Analysis, Trends, and Scope 2021 to 2022

Buy Now

mRNA Sequencing Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 1,356.94 Million
Market Size by 2030	US$ 3,662.50 Million
Global CAGR (2022 - 2030)	13.2%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Type Products and Services By Method First Generation Sequencing Next Generation Sequencing Third Generation Sequencing By End User Healthcare Facilities Pharmaceutical and Biotechnology Companies Clinical Research Organizations
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Takara Bio Inc Illumina Inc QIAGEN F Hoffmann La Roche Ltd Quantabio Zymo Research Corporation baseclick GmbH Paragon Genomics Inc Yeasen Biotechnology Shanghai Co Ltd Novogene Co Ltd

Industry Developments and Future Opportunities:

The mRNA sequencing market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players operating in the mRNA sequencing market are listed below:

In November 2023, Lexogen, announced the product launch of "LUTHOR High-Definition single Cell 3 mRNA-Seq Kit". LUTHOR HD can detect single gene copy within a cell, enabling researchers to get visuals of each cell's complete transcriptome, capturing 95% of expressed genes with high magnification.
In November 2023, PacBio, announced the expansion of "Multiplexed Arrays Sequencing (MAS-Seq) for new assays. This development is developed on the successful "MAS-Seq" concatenation technology that enables cost-effective single-cell isoform sequencing. The technology possesses key applications such as bulk RNA sequencing and 16 S rRNA, ultimately providing customers with cost-effective kit solutions and end-to-end software.

Competitive Landscape and Key Companies:

Takara Bio Inc.; Illumina, Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Quantabio; Zymo Research Corporation; baseclick GmbH; Paragon Genomics, Inc.; Yeasen Biotechnology (Shanghai) Co., Ltd.; Novogene Co, Ltd; and Norgen Biotek Corp are among the prominent companies profiled in the mRNA sequencing market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.